The z-spectrum from human blood at 7T by Shah, Simon M. et al.
NeuroImage 167 (2018) 31–40Contents lists available at ScienceDirect
NeuroImage
journal homepage: www.elsevier .com/locate/neuroimageThe z-spectrum from human blood at 7T
Simon M. Shah a,*, Olivier E. Mougin a, Andrew J. Carradus a, Nicolas Geades a, Richard Dury a,
William Morley a, Penny A. Gowland a,b
a Sir Peter Mansﬁeld Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, UK
b NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham, UKA R T I C L E I N F O
Keywords:
Chemical exchange saturation transfer (CEST)
Nuclear overhauser enhancement (NOE)
Z-spectrum
Magnetisation transfer
Blood relaxometry* Corresponding author.
E-mail address: simon.shah@nottingham.ac.uk (S.M. S
https://doi.org/10.1016/j.neuroimage.2017.10.053
Received 18 August 2017; Accepted 25 October 2017
Available online 27 October 2017
1053-8119/© 2017 The Authors. Published by Elsevier InA B S T R A C T
Chemical Exchange Saturation Transfer (CEST) has been used to assess healthy and pathological tissue in both
animals and humans. However, the CEST signal from blood has not been fully assessed. This paper presents the
CEST and nuclear Overhauser enhancement (NOE) signals detected in human blood measured via z-spectrum
analysis. We assessed the effects of blood oxygenation levels, haematocrit, cell structure and pH upon the z-
spectrum in ex vivo human blood for different saturation powers at 7T. The data were analysed using Lorentzian
difference (LD) model ﬁtting and AREX (to compensate for changes in T1), which have been successfully used to
study CEST effects in vivo. Full Bloch-McConnell ﬁtting was also performed to provide an initial estimate of ex-
change rates and transverse relaxation rates of the various pools. CEST and NOE signals were observed at 3.5 ppm,
1.7 ppm and 3.5 ppm and were found to originate primarily from the red blood cells (RBCs), although the
amide proton transfer (APT) CEST effect, and NOEs showed no dependence upon oxygenation levels. Upon lysing,
the APT and NOE signals fell signiﬁcantly. Different pH levels in blood resulted in changes in both the APT and
NOE (at 3.5 ppm), which suggests that this NOE signal is in part an exchange relayed process. These results will
be important for assessing in vivo z-spectra.Introduction
Z-spectrum features, in particular chemical exchange saturation
transfer (CEST) have recently been used to study both healthy and
pathological tissues in vivo (van Zijl and Yadav, 2011; Zaiss and Bachert,
2013; Liu et al., 2013), but so far there has only been one study of the z-
spectrum of blood (Zheng et al., 2014). The z-spectrum provides a means
of indirectly studying proton pools that are conventionally invisible to
MRI, opening up the possibility of metabolic imagingwithMRI (Cai et al.,
2012; Walker-Samuel et al., 2013; Rivlin et al., 2013; van Zijl et al., 2007;
Haris et al., 2014; Cai et al., 2015).
CEST (Zaiss and Bachert, 2013; Ward et al., 2000; Zhou and van Zijl,
2006) uses the principles of magnetisation transfer (MT) to investigate
moieties containing labile protons by applying saturation at their reso-
nant frequency and detecting the subsequent transfer of the saturation to
the water pool via chemical exchange. The transferred saturation can
only be detected if the chemical exchange is fast compared to the lon-
gitudinal recovery rate but in the slow to intermediate regime compared
to the chemical shift between the water and the labile protons. Amide
proton transfer (APT) CEST is associated with mobile amide protons athah).
c. This is an open access article undeþ3.5 ppm relative to water. It is sensitive to pH (Zhou et al., 2003) and
has been applied to study ischemia and tumour grading, but its origins
are not fully understood. The increase in APT in tumours has been
attributed to an increase in the content of endogenous cellular proteins
and peptides, despite the fact that the total content of proteins has been
shown to be relatively constant in tumours (Yan et al., 2015). Amines
(NH2) at 2.2 ppm are in faster exchange than APT, but are infrequently
detected in vivo since high saturation powers are required. The amine
signal has previously been used as a marker for pH (McVicar et al., 2014).
The NOE signal at 3.5 ppm was believed to originate from regions of
high myelination (Mougin et al., 2013; Jones et al., 2013) however, more
recently Xu et al. showed that there is no NOE contrast difference be-
tween grey and white matter when the magnetisation transfer contrast is
suppressed (Xu et al., 2016). The NOE signal may also be decreased in
tumours (Zaiss et al., 2015) but this is probably related to increased water
content and requires further investigation. Jones et al. also investigated
multiple NOE peaks associated with the macromolecule MRS spectrum
(Jones et al., 2013), and Zhang et al. observed a ‘new NOE peak around
-1.6 ppm’ and showed it was reduced in ischemic stroke (Zhang
et al., 2016).r the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
The number of blood samples taken during the experiments across the 4 healthy male
volunteers.
Type of sample Number of Samples
Control (4 ml) 4
Oxygenated (4 ml) 4
Deoxygenated (4 ml) 3
Concentrated RBCs (2  4ml) 4
Plasma (2  4ml) 2
Clotted (5 ml) 2
pH 6.8 (4 ml) 1
pH 7.0 (4 ml) 1
pH 7.4 (4 ml) 1
Total 24
S.M. Shah et al. NeuroImage 167 (2018) 31–40Zheng et al. found that blood has increased CEST contrast relative to
some other tissues (Zheng et al., 2014). However they assessed the CEST
signal using MT asymmetry (Zhou et al., 2004), which is sensitive to
competing effects of NOE (3.5 ppm) and APT (þ3.5 ppm) particularly
at high ﬁeld.
Asymmetry analysis was the original method used to analyse CEST
and NOE signals from in vivo MRI but recently alternative quantiﬁcation
approaches have been proposed, such as Lorentzian difference (LD)
ﬁtting and AREX (Zaiss et al., 2011). LD ﬁtting can characterise slow and
intermediate exchanging proton pools but is not suitable for faster
exchanging proton pools (such as amines and hydroxyls) which coalesce
with the water signal (Zaiss and Bachert, 2013). To directly estimate the
absolute sizes of the exchanging pools relative to water it is necessary to
ﬁt the data to a multi-pool Bloch-McConnell (BM) model (van Zijl and
Yadav, 2011; Chappell et al., 2013; Geades et al., 2017). BM ﬁtting is
more time consuming than LD ﬁtting and AREX, requires some a priori
knowledge of parameters such as T2 and kex of each exchanging proton
pool, and generally requires larger datasets to be used in the ﬁt.
This work aims to investigate the CEST and NOE signals visible in ex
vivo blood, considering the effects of oxygenation, haematocrit, cell
structure and pH, quantifying the results using AREX and also direct BM
ﬁtting to provide initial estimates of the exchange rates and transverse
relaxation times of the various pools.
Methods
In vivo human data
With local ethical approval, 2 male subjects aged 31 and 35 were
recruited and z-spectra were acquired from the head.
Blood collection and preparation
With local ethical approval, a total of 98 ml of venous bloodwas taken
from 4 healthy male volunteers and was stored in vials containing an
anticoagulant (heparin) or allowed to clot. The unclotted samples were
then treated in various ways with the number of samples used for each
treatment shown in Table 1.
Either 120 ml of nitrogen gas or medical (100%) oxygen was bubbled
through the blood to deoxygenate or oxygenate it. To achieve this two
syringe needles were pushed through the rubber seal of the vials, one
connected to a 60 ml syringe to the relevant gas, and the second to
exhaust gas from the vial to prevent pressure rise. A very low gas ﬂow
rate was used to prevent foaming (Gardener et al., 2010) and the vials
were regularly inverted to ensure good mixing. A blood gas analyzer
(i-STAT, Abbott) was used to measure the samples’ saturation of oxygen
(SO2), partial pressure of oxygen (PO2), pH and haematocrit (Hct) levels.
8 ml of unmodulated blood was spun in a centrifuge (15 min at
800 rpm) and the plasma was removed. Two such samples were com-
bined to give a concentrated RBC (cRBC) sample with 40% greater Hct
level than whole blood. The remaining 12 ml of blood samples were
washed with a phosphate saline buffer to modify the pH to 6.8, 7.0 and
7.4. MR scanning was commenced within one hour of blood collection.
At the end of scanning, the blood was frozen and defrosted within a week
to lyse the blood cells before repeating the scan. This method of lysis
causes cells in the blood to swell and ultimately break as ice crystals form
during the freezing process. The cell skeletons were left in the samples
during the repeated scanning.
A sample of heparinized water was also scanned.
For MR scanning the vials were placed in a temperature controlled
holder. The holder was designed to allow warm water to ﬂow slowly
around the samples to keep them at 37 C (PMT Instruments). The holder
was rotated every 4 minutes during scanning to limit blood sedimenta-
tion, and could be repositioned after each rotation with a mean
displacement of 0.01± 0.02mm in the x-direction and 0.11± 0.05mm in
y-direction.32MRI acquisition
All MRI experiments were conducted on a 7T Philips Achieva with a
volume transmit RF coil and Nova 32 channel receive coil. Z-spectra were
obtained using a saturation-prepared 3D TFE sequence (Mougin et al.,
2013) shown in Fig. 1. The pulse sequence involved a train of 40
Gaussian windowed sinc RF pulses with bandwidth 200 Hz and a duty
cycle of 50% applied prior to a TFE readout with a low-high radial
k-space acquisition scheme.
The pulses were phase cycled and a spoiler gradient was applied at the
end of the pulse train to remove residual transverse magnetisation.
Further details are given in Table 2.
An additional acquisition was made with a presaturation at 167 ppm,
which was assumed not to saturate any exchangeable magnetisation. This
data point was used to estimate M0 for normalisation, since we had
previously observed that off-resonance pre-saturation resulted in a small
change in the amplitude of the readout pulses.
B0 and B1 (AFI (Yarnykh, 2007)) maps were acquired to correct for
the ﬁeld inhomogeneities (allowing no change in transmitter calibration
between acquisition of the B1 map and the z-spectrum). T1 maps were
acquired using an inversion recovery sequence with FOV
224  224  48 mm3 and voxel size 1.5  1.5  2 mm3, TI ¼ 150, 200,
300, 400, 500, 600, 700, 800, 1000, 1200, 1500, 1800, 2200, 3000,
3500, 4000, 4500 and 5000 ms, TR/TE ¼ 6.9/3.2 ms and SENSE factor
(RL) of 2. T2* maps were acquired using a multi-gradient echo
(echos ¼ 8) with FOV 256  256  48 mm3 and voxel size
2  2  2 mm3. TR/TE ¼ 45/1.35 ms and ΔTE ¼ 1.8 ms.Data processing
Voxel-wise z-spectra were obtained for each RF saturation power by
calculating
ZðΔωÞ ¼ Mz;satðΔωÞ=M0 (1)
at each off-resonance (Δω), with normalisation by the signal M0 acquired
at 50 kHz (167 ppm). The z-spectra were B0 corrected by interpolating to
0.01 ppm resolution between ±17 ppm, then shifting the entire spectrum
by the difference between the B0 map and the zero point at 0 ppm, and
ﬁnally re-sampling back to the original off-resonance frequencies (Zaiss
and Bachert, 2013; Zhou et al., 2003).
The B1 map was used to estimate the actual saturation amplitude at
which each z-spectrum from each voxel was acquired. Next the z-spectra
for the target B1 amplitudes of 0.5, 0.9 and 1.3 μT were estimated by
using spline interpolation between measured z-spectra up to 1.5 μT,
including an additional point at 0 μT (Windschuh et al., 2015).
The T1 relaxation time was calculated by ﬁtting the inversion re-
covery data to M ¼ M0ð1 α expðTI=T1Þ where α accounted for
incomplete inversion. T2* was calculated by ﬁtting the natural log of 8
gradient echoes to a linear decay using a weighted least-squared ﬁtting
algorithm, excluding any data that fell below background noise.
Fig. 1. The magnetisation transfer-prepared turbo ﬁeld echo (MT-TFE) sequence: a presaturation period followed by the TFE readout. The presaturation period consists of N ¼ 40 Gaussian
windowed sinc pulse. The duty cycle of 50% was used such that t ¼ 30 ms and T ¼ 60 ms. The crusher gradient at the end of the saturation train removes any residual transverse
magnetisation. np ¼ 2 and na ¼ 4 are the number of ramped RF pulses before and at the start of the acquisition, respectively. From (Mougin et al., 2013).
Table 2
MR sequence parameters for the blood samples and in vivo acquisition.
Blood samples In vivo
B1max (μT) 2.4, 4.9 and 8.5 2.4 and 6.0
B1,rms (μT) 0.43, 0.87 and 1.52 0.43 and 1.1
Off resonance
frequencies (ppm)
83 off-resonance frequencies between ± 17 ppm, and at
50 kHz (167 ppm).
38 and 23 off-resonance frequencies between ±33 ppm, and at 50 kHz (167 ppm) for 2.4 μT
and 6.0 μT respectively
FOV (mm3) 224  224 x 48 192  186 x 50
Resolution (mm3) 1.5  1.5 x 2 1.5  1.5 x 1.5
TE/TR/FA 2.6 ms/5.55 ms/8 2.8 ms/6 ms/8
SENSE (RL) 2 2
Number of TFE shots 5 4
Table 3
Starting parameters used for the 6 pool Bloch-McConnell ﬁtting of the z-spectra acquired on






T2 (ms) 0.5 10 1.2 0.5 0.01
Exchange rate (Hz) 20 500 1.5 5 15
Assumed frequency offset from
water (ppm)
3.5 2.2 1.7 3.5 2.34
Assumed T (ms) 1000 1000 1000 1000 1000
S.M. Shah et al. NeuroImage 167 (2018) 31–40To quantify changes in CEST and NOE components, initially Lor-
entzian difference (LD) model ﬁtting was performed (Zaiss et al., 2011),
assuming that the z-spectra could be approximated by a linear combi-
nation of Lorentzian functions corresponding to amides (nominally at
3.5 ppm), amines (nominally at 2.2 ppm), the NOEs (nominally at 3.5
and 1.7 ppm), and a Lorentzian corresponding to the MT from mac-
romolecules (Hua et al., 2007; Morrison and Henkelman, 1995). The LD
model was ﬁtted to the B1 corrected z-spectra using a least-square algo-
rithm, allowing the positions of the CEST and NOE peaks to vary by ±
0.4 ppm around the predicted literature values, and the amplitude and
width of the peaks to vary. The variations in the position and width of the
peaks accounted for the differences in T2* and frequency offset between
oxygenated and deoxygenated blood.











where T1 was the observed longitudinal relaxation time, Zlab(Δω) was the
measured Z-value (Equ. 1) at off-resonance frequency Δω and Zref(Δω)
was the Z-value from the summation of all ﬁtted Lorentzians, except for
the Lorentzian for the proton pool of interest at Δω. Whilst AREX can
compensate for changes in T1 between the fresh and lysed blood samples,
it cannot be computed over the total width of the Lorentzian lineshape,
and therefore the peak amplitude of the ﬁtted Lorentzian was used. AREX
assumes steady state has been achieved and breaks down close to 0 ppm
due to the inverse in Equ (2), and therefore it is difﬁcult and sometimes
impossible to calculate AREX values for the amines (2.2 ppm) and NOE-
1.7ppm (Heo et al., 2017). Additionally the amine (and other hydroxyls
pool) peaks coalesce with the water peak, making them difﬁcult to
separate the signals when performing Lorentzian lineshape ﬁtting.
We also ﬁtted the z-spectra acquired at three B1 saturation powers
(162 data points in total) jointly to a 6-pool BM model (Woessner et al.,
2005) to provide absolute estimates of the pool sizes Mi,0/Mf,0, Ti2, and
exchange rate ki,ex of each (ith) exchanging proton pool in an iterative
manner. These ﬁts were carried out on the University of Nottingham
High Performance Computer. The model only allowed for exchange be-
tween the off-resonance pools and free water, assuming that direct33exchange between the other pools was negligible. Initially the three
spectra from the control blood sample were ﬁtted to the 6-pool model
using a genetic algorithm to obtain an initial estimate of the 16 param-
eters (5 Mi,0/Mf,0, 6 Ti2, and 5 ki,ex), assuming the water longitudinal
relaxation time measured with the inversion recovery experiment, and
the RF amplitude from the B1 map. The starting values for this ﬁt are
given in Table 3; these values were taken from brain data (van Zijl et al.,
2017) adjusted from preliminary BM ﬁts. We made an estimate of the
errors in the ﬁtted parameters by considering the span of possible ﬁtted
parameter values consistent with doubling in the sum of squares at the
ﬁtted value (which would correspond to halving the signal to noise ratio
(SNR) in the spectra if the error in the ﬁt were purely due to
random noise).
Next these results were used to estimate the pool sizes Mi,0/Mf,0 for
the fresh and lysed control and concentrated samples, assuming no
change in Ti2, and ki,ex. This approach allowed better comparison of the
relative pool sizes than if Ti2, and ki,ex had been allowed to vary freely.
The data from each sample were ﬁtted for 5 parameter to the 6-pool
model. For each sample the T2 of water was estimated from the linewidth
of the direct saturation (DS) peak within 400 Hz of resonance.
Results
In vivo APT and amine maps from one volunteer produced by LD
ﬁtting are shown in Fig. 2(a–b). Fig. 2(c–d) show the z-spectra and AREX
spectra for the regions of interest indicated in Fig. 2(a). Both spectra
suggest high APT and amine signals and low NOE signals in the sagittal
sinus compared to white matter and grey matter. Similar results were
obtained in the other volunteer. Fig. 2(c) shows that the MT asymmetry1
S.M. Shah et al. NeuroImage 167 (2018) 31–40observed in WM and GM is not present in blood.
Fig. 3 shows the (a) oxygen saturation (SO2), partial pressure of ox-
ygen (PO2), haematocrit, pH and (b) average T1 and T2*, of each set of
samples. For all oxygenated samples the SO2 reached 100% after prep-
aration and maintained this level for the duration of the experiment. The
SO2 of the deoxygenated and control blood was approximately 40% and
80% respectively. Both samples’ oxygenation levels changed during the
experiment (control SO2 increased and deoxygenated SO2 decreased)
because the gas in the space above the blood in the vials continued to
exchange with the red blood cells. The oxygenated and deoxygenated
blood had a PO2 of approximately 60 and 3 mmHg respectively. The pH
levels for all the samples were between 7.3 and 7.5 during scanning, with
a drop of pH 0.2–0.3 detected over the course of scanning. The Hct was
approximately 40% for the control, oxygenated and deoxygenated blood,
over 70% for the concentrated RBCs and less than 10% for plasma.
Fig. 3(b) shows that the T2* of the deoxygenated blood was approx-
imately ﬁve times shorter than that of the oxygenated and control blood
samples. The concentrated RBCs had a shorter T2* than the oxygenated
and control blood (and also a somewhat lower SO2), and the plasma had a
much longer T2* than all the other samples. Lysing the blood shortened
the T1 and lengthened T2* for all the blood samples.
The z-spectrum of heparinized water only showed the DS peak.
Figure 4(a) shows B1 corrected example z-spectra for concentrated
RBCs and plasma, including an inset of the AREX spectra. The longer T2*
of plasma gave a narrower lineshape around 0 ppm, but these spectra
indicate that the largest source of the MT, CEST and NOE signal in the
blood is from the RBCs rather than plasma. Fig. 4(b) shows no signiﬁcantFig. 2. Lorentzian difference maps (B1 corrected to a target of 0.5 μT) for (a) APT and (b) am
removed) for the three ROIs indicated on the APT map are also shown.
34difference in NOE and CEST peaks between the z-spectra for oxygenated
and deoxygenated blood. The wider DS peak of the deoxygenated blood
is expected due to its shorter T2* (Table 4). Fig. 4(b inset) shows the
AREX spectra, further suggesting that there no signiﬁcant difference in
the NOE and CEST peaks between the oxygenated and deoxygen-
ated spectra.
Fig. 4(b) and (c) suggest considerable changes in the z-spectra after
lysing the blood, highlighted in Fig. 4(d) which directly compares z-
spectra from fresh and lysed cRBCs. Whilst the most signiﬁcant changes
in the spectra are due to the changes in relaxation times, the NOE-1.7ppm
signal is not apparent in the lysed blood despite the reduction in DS in
this region of the spectrum (Fig. 4(d) inset). Fig. 4(e) shows there is little
change in the z-spectra on clotting the concentrated RBCs except for a
reduction in the NOE-1.7ppm signal (Fig. 4(e) inset).
The LD model ﬁtted the spectra well and the results are shown in
Table 4. In the LD ﬁtting we assumed a symmetric MT lineshape as
observed in the ex vivo blood and sagittal sinus spectra. However, we also
attempted to ﬁt an asymmetric MT lineshape but the AREX results
were unchanged.
Fig. 5 shows the AREX signals for the NOE-3.5ppm, APT, amine and MT
for both the fresh and lysed oxygenated, deoxygenated, control and
concentrated RBCs blood samples, for the three saturation powers
separately. NOE-1.7 ppm AREX values could not be calculated as they tend
to inﬁnity due to their close proximity to the DS peak (Heo et al., 2017).
The NOE-3.5ppm, APT, and amine AREX signals showed an average 40%
increase between the control sample and concentrated RBCs samples.
The NOE-3.5ppm AREX signal showed a trend to be higher at low B1ine maps. The corresponding (c) z-spectra (d) AREX spectra (with the MT contribution
(a)
(b)
Fig. 3. (a) The saturation of oxygen (SO2), partial pressure of oxygen (PO2), pH levels and the haematocrit levels of the control, oxygenated, deoxygenated, concentrated RBCs and plasma
blood samples, and (b) the average T1 and T2* for fresh and lysed blood samples separately.
S.M. Shah et al. NeuroImage 167 (2018) 31–40power for all samples, whereas the APT, amine andMT pools sizes tended
to increase across all B1 powers, except for the control sample amine
AREX signal which dropped at high power, possibly because of its close
proximity to the DS peak.
Comparing the control, oxygenated and deoxygenated blood samples
for each power with 2 way-ANOVA, the NOE-3.5ppm AREX pool showed
no signiﬁcant change with oxygenation (p¼ 0.59), but upon lysing fell by
an average of 27% for all samples (p ¼ 0.003). The APT signal also
showed no signiﬁcant change on oxygenation (p ¼ 0.67) and fell by an
average of 22% (p ¼ 0.01) on lysing. There was no signiﬁcant difference
between the fresh and lysed amines (p ¼ 0.06). The MT signal fell by an
average of 60% on lysing (p ¼ 0.017) for the 1.3 μT saturation (the low
power signal was too small to compare).
Fig. 6 shows effects of pH on the z-spectra and AREX signal when the
blood was buffered to pH 6.8, 7.0 and 7.4, and suggests that both the
NOE-3.5ppm and APT exchanges are base catalysed.
Fig. 7(a) shows the Bloch-McConnell 6-pool model ﬁtted to z-spectra
obtained for the fresh and lysed control blood samples as well as for the
fresh and lysed concentrated RBCs for three different combination of B1
saturation powers. Table 5 shows the results of the 16 parameter ﬁt with
ranges of ﬁtted values consistent with halving the SNR as an indication of
the uncertainty in the ﬁt. The apparent range T2s of the APT and amine
exchanging proton pools in Table 5 are shorter than those previously
found in grey matter, whilst the T2 of the MT is longer.
Fig. 7(b–f) show the results of the ﬁnal 5 parameter ﬁt to the 6 pool
model for the fresh and lysed control and concentrated samples and
compares the results to AREX for the mid saturation power (taken
from Fig. 5).35Discussion
Signiﬁcant CEST signals can be detected from major blood vessels on
in vivo MRI and here we have shown that these signals can also be
detected in blood ex vivo. Amide and amine (which are related to proteins
and amino acids) signals and two NOE peaks were detected in the z-
spectrum from blood. The results indicate that these signals originate
largely from RBCs and do not depend signiﬁcantly upon blood oxygen-
ation. Upon lysing the blood we observed a signiﬁcant decrease in the
amide, NOE-3.5ppm and MT AREX signal and the NOE-1.7ppm peak dis-
appeared (inset in Fig. 4(d)). The source of NOE-3.5ppm signal is currently
under debate but is assumed to derive from aliphatic and oleﬁnic protons
in mobile proteins involving direct dipole-dipole interactions and
exchanged relayed interactions (Jones et al., 2013) (in the brain
NOE-3.5ppm has been reported to be closely related to myelin (Mougin
et al., 2013)).
Any z-spectrum signal from blood is crucial for the interpretation of
endogenous z-spectrum signals detected in vivo. For example the effect of
a change in blood volume must be considered when studying a change in
APT signal from a tumour, or the effects of possible blood break down
products must be considered when studying a patient with a stroke.
Fig. 4(a) indicates that the z-spectrum features arise largely from the
red blood cells rather than the plasma. Signals were observed in the z-
spectrum of plasma (Fig. 4(a)) probably related to amines in albumin and
other plasma proteins and possibly residual red blood cells, but the
longer T1 of the plasma (Fig. 2(b)) will have accentuated the exchanging
peaks. To account for this we calculated the T1 corrected AREX spectra
(Fig. 4(a) inset) and found that the NOE, APT and MT signals were more
than 8 times greater in the cRBC samples than the plasma samples.
Fig. 4. B1 corrected z-spectra for the (a) fresh plasma and concentrated RBCs with (inset) the AREX spectra for the fresh cRBCs and plasma, (b) fresh oxygenated and deoxygenated blood
with (inset) the AREX spectra for the fresh oxygenated and deoxygenated blood, (c) B1 corrected z-spectra for the lysed oxygenated and deoxygenated blood with (inset) a zoom in around
1.7 ppm, (d) fresh and lysed concentrated RBCs and (e) fresh and clotted concentrated RBCs with (inset) a zoom in around 1.7 ppm. All are presented at the target B1 saturation powers
of 0.5, 0.9 and 1.3 μT.
Table 4
The peak widths and position for APT, amines, NOEs, DS and MT from the LD model ﬁtting.
APT Amines NOE-1.7ppm NOE-3.5ppm DS MT
Fitted peak position averaged over all samples (ppm) 3.55 ± 0.04 2.08 ± 0.02 Fixed at
1.7 ppm
3.49 ± 0.01 0.02 ± 0.02 0.43 ± 0.19
Fitted peak width for oxygenated samples (ppm) 3.5 ± 0.3 1.90 ± 0.09 0.52 ± 0.05 4.7 ± 0.2 1.62 ± 0.04 36.8 ± 4.2
Fitted peak width for deoxygenate-d samples (ppm) 3.2 ± 0.1 2.90 ± 0.02 1.3 ± 0.2 4.4 ± 0.2 2.17 ± 0.07 40.0 ± 1.9
S.M. Shah et al. NeuroImage 167 (2018) 31–40There was an increase in all z-spectrum features in the concentrated
red blood cell sample (Fig. 4(a) and (b)), and the AREX which gives a
relative signal for NOE-3.5ppm and APT, showed there was an average 40%
increase between the control, oxygenated or deoxygenated samples and,
the concentrated RBCs samples, which corresponds to the measured in-
crease in haematocrit (42%). Similar results were obtained for the BM ﬁt36except for NOE-3.5ppm which was underestimated for lysed cRBCs. The pH
was measured before and after scanning, and a drop in pH of 0.2–0.3 for
all the blood samples was detected which would have modiﬁed the re-
sults since exchange rates of amides (and amines to a lesser extent) are
base catalysed (Zhou et al., 2003).
Deoxygenated haemoglobin is highly paramagnetic and oxygenated
Fig. 5. The calculated AREX from the Lorentzian lineshape ﬁtting, showing the NOE-3.5ppm, APT3.5ppm and Amine2.2ppm and MT-2.4ppm signals for the deoxygenated, control, oxygenated
and cRBCs blood samples for the target saturation powers 0.5, 0.9 and 1.3 μT. Statistical (2 way ANOVA) tests showed that were signiﬁcant differences between the fresh and lysed blood
samples, across the saturation powers.
S.M. Shah et al. NeuroImage 167 (2018) 31–40haemoglobin is slightly diamagnetic relative to plasma, whilst dissolved
oxygen makes plasma paramagnetic. In deoxygenated blood this results
in magnetic ﬁeld gradients around the red blood cells leading to the
observed shorter T2* and broader DS peak (Weisskoff and Kiihne, 1992).
The net frequency of the sample will also have been shifted by 0.48 ppm
up-ﬁeld (Gasparovic and Matwiyoff, 1992), but we only considered
relative frequency shifts. A small negative variation of T1 with oxygen-
ation might have been expected (d'Othee et al., 2003; Blockley et al.,372008) but in fact the control blood had the longest T1. This was probably
because the oxygenated samples all had an SO2 of 100% causing oxygen
to be dissolved in the plasma reducing T1 (Ma et al., 2016). The T1 of (not
oxygenated) plasma was similar to CSF. The main observable difference
between the z-spectra of oxygenated and deoxygenated blood (Fig. 4(b))
was the narrower DS peak consistent with the fact that the samples had
similar T1s and very different T2*s. However, the results of the AREX
ﬁtting, was performed separately at each power, do suggest some trends
Fig. 6. (a) Z-spectra for blood with pH 6.8, 7.0 and 7.4 showing an effect on the APT and NOE-3.5ppm signal change at B1 corrected target saturation power of 0.5 μT (b) AREX for the APT,
NOE-3.5ppm and Amines at a target power of 0.5uT respectively for the blood with pH 6.8, 7.0 and 7.4.
Fig. 7. (a) 16 parameters ﬁtted using the 6 pool Bloch McConnell equations on the control fresh blood sample. The ﬁt results are presented in Table 5 (b–f) Estimated pool size of NOE-
3.5ppm, APT, Amines MT and NOE-1.7ppm from the ﬁnal 5 parameter Bloch McConnell ﬁt. vs. the AREX results for the target B1 saturation of 0.9 μT are also shown. The AREX signal cannot be
calculate for NOE-1.7ppm.
S.M. Shah et al. NeuroImage 167 (2018) 31–40for the amine signal to increase with oxygenation, possibly related to the
change in conformation of the haemoglobin molecule (which contains38histadine) on oxidation (the results at high power are less reliable due to
the effects of DS on the AREX calculation close to resonance).
Table 5
Results of the 16 parameter ﬁt to the 6 pool Bloch-McConnell ﬁtting of the z-spectra acquired on the control blood samples, together with an indication of the uncertainty in the ﬁt.
APT Amines NOE -1.7ppm NOE-3.5ppm MT
Pool concentration (%) 0.78 0.39 1.80 1.44 1.05
0.78–1.29 0.01–0.64 0.58–2.80 0.44–2.47 0.36–1.30
Exchange rate (Hz) 33.1 338.7 6.35 4.9 10.3
6.3–50.0 120–481 5.3–15.6 2.9–10 10.3–27.8
T2 (ms) 1.4 30.7 1.5 5.9 0.093
1.4–6.5 13.6–58.7 1.5–8.4 1.4–9.0 0.023–0.093
S.M. Shah et al. NeuroImage 167 (2018) 31–40After lysing, T2* increased for all blood samples, which is expected
because of the homogenization of the sample. T1 decreased particularly
for the deoxygenated sample which may be related to the fact that lysing
can lead to the formation of methaemoglobin which has a particularly
high T1 relaxivity. After lysing the DS peak was narrowed and the MT
baseline, CEST and NOE features reduced in amplitude which would be
consistent with the known effects assuming an increase in T2* and a
reduction in the T1. Both AREX and the BM analysis attempt to correct for
the effects of such changes in T1, and indicated a signiﬁcant reduction in
NOE-3.5ppm, APT and MT on lysing. The reduction in MT, APT and NOE-
3.5ppm upon lysing suggests that these are related to the semi-solid
intracellular and membrane components which are denatured as the
RBCs are destroyed. The AREX NOE-3.5ppm in the plasma (Fig. 4(a)) is
likely to be associated with albumin but was measured to be 7 times less
that the AREX NOE-3.5ppm in the lysed cRBCs (results not shown). Lysing
is associated with both conversion of haemoglobin to methaemoglobin
and changes in the cell membrane, but the trend for the NOE-3.5ppm AREX
signal to be reduced particularly for the oxygenated blood, might point to
this effect originating in haemoglobin.
Clotting had surprisingly little effect on the z-spectrum. However
both lysing and clotting caused the NOE-1.7ppm peak to disappear. This
could not be quantiﬁed by AREX since the NOE-1.7ppm peak was so close
to the DS peak. Similarly the BM ﬁt did not properly ﬁt the NOE-1.7ppm for
the cRBCs, probably due to its sensitivity to the estimate of T2. AREX
quantiﬁcation of amines has only been successfully employed at 9.4T
(Zhang et al., 2017b). Examining all the z-spectra the NOE-1.7 ppm signal is
visible in the unclotted, unlysed blood, and particularly in cRBCs, and at
low pH. This could be related to a result recently reported by Zhang et al.
who examined an 'NOE mediated MT effect around 1.6 ppm’ and
observed a strong contrast difference between healthy and stoke tissue in
rats (Zhang et al., 2016). Future work will focus on determining this
frequency more precisely. At increased ionic strength (or osmolarity) red
blood cells can form echinocytes (or burr cells) losing their discoid shape
and gaining small protrusions on their surface, associatedwith separation
of the lipid bilayer from the underlying membrane skeleton (Liu et al.,
1989), and similar effects are observed in vivo in various situations where
the cells are under stress. Previous work using 1H NMR suggests that
echinocyte formation is associated with changes in the distribution of
phospholipids between the two leaﬂets of the cell membrane (Pages
et al., 2010). It has recently been shown that reconstituted egg phos-
pholipids show an NOE-1.7ppm peak (Zhang et al., 2017a). It seems
possible that morphological transformation of the cell membrane is in
some way responsible for the change in the NOE-1.7 ppm peak although
further work including optical microscopy is required to conﬁrm this.
The increase in the amine signal estimated by AREX with B1 is
consistent with amines being in faster exchange than the other pools and
thus requiring more B1 saturation power to observe magnetisation ex-
change of the protons of interest. The discrepancy for the control sample
at high power is due to the broad DS peak which perturbed the LD model
ﬁt for that sample. There is good agreement between AREX at medium
power and the BM model as shown in Fig. 7.
In this work the data were analysed quantitatively in two ways: by
ﬁtting to an LD model with AREX analysis which yields a relative CEST or
NOE proton signal but does not measure the pool sizes, and by ﬁtting to a39BM model which gives absolute proton pool sizes (relative to the water
pool) and an estimate of Ti2, and ki,ex for the exchanging pools. Fig. 7 shows
generally good agreement between the relative pool sizes estimated from
the two methods. However only relative quantiﬁcation is possible with
AREX. For instance for LD ﬁtting, spline interpolation was used to correct
for B1 ﬁeld inhomogeneities at 7T (Windschuh et al., 2015; Jones et al.,
2011), but the AREX results clearly varied with B1 saturation power in a
way that depended on exchange rate (Jones et al., 2011). AREX is also
unable to cope with coalescing peaks, particularly close to the water peak.
Furthermore the AREX theory was derived for a spin system in a steady
state (Jones et al., 2011), which may not be achieved for samples with
longer T1 using a ﬁnite train of saturation pulses. Simulations of the pre-
saturation pulse trains used in our experiments (40 pulses in 2.4 s) showed
the system achieved approximately 95% of steady state at the end of the
pulse train. The full BM ﬁt does not require the system to reach steady
state. The BM ﬁt was performed on a subset of the samples which allowed
us to test whether it was possible to detect changes expected due to
changes in concentration, but it was still compromised for NOE-1.7ppm
probably due to errors in the estimate of T2 which are likely to have also
affected the ﬁt to the amine peak. The exchange rates and relaxation times
measured in the control blood sample from the BMﬁt were generally of the
same order of magnitude as the values measured in the brain (van Zijl
et al., 2017). The T2 values were somewhat shorter than previously re-
ported, despite the fact that the blood was less structured than brain tissue.
This may indicate that the peaks identiﬁed actually correspond to multiple
peaks which have not been accounted for in the BM model. The exchange
rates measured for amines suggest that they may originate more in gua-
nidinium (which can be found in creatine and the arginine side groups in
proteins) at 2 ppm rather than glutamate at 3 ppm (van Zijl et al., 2017)
since the guanidinium proton group has a lower exchange rate than amine
protons (Chen et al., 2017). In general the relaxation times measured were
shorter which might be expected given the reduced structure in blood
compared to grey matter. These values can provide starting values for
future investigations of blood and possible multicompartmental modelling
of tissue. Future work will use continuous wave saturation to provide
improved spectra and will ﬁt a range of samples to explore the effects of
blood oxygenation and pH on Ti2, and ki,ex.
Conclusion
This work has shown that the CEST and NOE effects seen in z-spectra
of ex vivo blood originate primarily from the RBCs and that the z-spec-
trum from blood shows a diverse range of CEST and NOE effects, some of
which depend on whether or not the cells have been lysed. These results
are crucial to our interpretation of in vivo z-spectra in pathology, where
changes in blood volume need to be considered.
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